Short vs Long Arm Cast for Distal Radius Fractures: the Verona Trial (SLA-Ver)
Short vs Long Arm Cast for Distal Radius Fractures: the Verona Trial. Randomized Clinical Trial to Assess the Efficacy of Short Arm Cast Versus Long Arm Cast in Conservative Management of Distal Radius Fractures
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Verona, Italy, 37126
- Ospedale Civile Maggiore Borgo Trento
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of distal radius fracture
- Indication to conservative treatment
- Need for manipulation to reduce fracture
Exclusion Criteria:
- Open fractures
- Existence of any skin lesion or wound that would impair cast treatment
- Neurovascular deficits
- Bilateral fractures
- Association with any other fracture of the homolateral arm
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Short arm cast
Patient treated with below-elbow cast
|
Application of a below-elbow cast
Other Names:
|
|
Active Comparator: Long arm cast
Patients treated with above-elbow cast
|
Application of an above-elbow cast
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary displacement ratio
Time Frame: 35 days
|
Percentage of fractures that displace during treatment as subjectively assessed on radiographs by investigators.
|
35 days
|
|
Variation of radial length
Time Frame: 35 days
|
Difference between radial length values as objectively measured on postreduction radiographs and endtreatment radiographs.
|
35 days
|
|
Variation of radial inclination
Time Frame: 35 days
|
Difference between radial inclination values as objectively measured on postreduction radiographs and endtreatment radiographs.
|
35 days
|
|
Variation of volar tilt
Time Frame: 35 days
|
Difference between volar tilt vaues as objectively measured on postreduction radiographs and endtreatment radiographs.
|
35 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-treatment elbow range of motion (ROM)
Time Frame: 35 days
|
Degrees of extension, flexion, pronation and supination of the elbow measured at the end of the treatment.
|
35 days
|
|
DASH score
Time Frame: 35 days
|
Disability of Arm, Shoulder and Hand score measured at the end of the treatment relating to patient's comfort during treatment.
|
35 days
|
|
SF-12
Time Frame: 35 days
|
Short Form 12 health questionnaire administered at the end of the treatment relating to patient's quality of life during treatment.
|
35 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Tommaso Maluta, MD, Azienda Ospedaliera Universitaria Integrata Verona
- Principal Investigator: Giovanni Dib, MD, Azienda Ospedaliera Universitaria Integrata Verona
- Principal Investigator: Matteo Cengarle, MD, Azienda Ospedaliera Universitaria Integrata Verona
- Principal Investigator: Alice Bernasconi, DR, Azienda Ospedaliera Universitaria Integrata Verona
- Principal Investigator: Franco Lavini, MD, Azienda Ospedaliera Universitaria Integrata Verona
- Study Chair: Andrea Scalvi, MD, Azienda Ospedaliera Universitaria Integrata Verona
- Study Chair: Bruno Magnan, MD, Azienda Ospedaliera Universitaria Integrata Verona
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1165CESC
- 1166CESC (Registry Identifier: Comitato Etico per la sperimentazione clinica delle province di Verona e Rovigo)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.